These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7109215)

  • 1. [Problems in blood transfusion (author's transl)].
    Tokunaga A
    Masui; 1982 Mar; 31(3):198-202. PubMed ID: 7109215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multiple sclerosis patients as blood donors (author's transl)].
    Zander H
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):379-80. PubMed ID: 4208095
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on blood component transfusion with continuous blood cell separator (IBM 2997). Part 1 : Effects of blood component extraction on donors (author's transl)].
    Toki H; Ishikawa M
    Rinsho Ketsueki; 1981 Oct; 22(10):1525-30. PubMed ID: 7334597
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood transfusion. II. Blood resources (author's transl)].
    Cazal P
    Rev Bras Pesqui Med Biol; 1975; 8(3-4):331-8. PubMed ID: 1215581
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan.
    Matsubayashi K; Nagaoka Y; Sakata H; Sato S; Fukai K; Kato T; Takahashi K; Mishiro S; Imai M; Takeda N; Ikeda H
    Transfusion; 2004 Jun; 44(6):934-40. PubMed ID: 15157263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prior transfusion history on blood donor anti-hepatitis C virus antibody.
    Mazda T; Nakata K; Ota K; Kaminuma Y; Katayama T
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():183-6. PubMed ID: 7886569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of transfusion transmitted infections in blood donors: an Indian experience.
    Chandra T; Kumar A; Gupta A
    Trop Doct; 2009 Jul; 39(3):152-4. PubMed ID: 19535750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood transfusion: I. Médico-social peculiarities and the fundamentals for its organization on a national basis (author's transl)].
    Cazal P
    Rev Bras Pesqui Med Biol; 1975; 8(3-4):315-25. PubMed ID: 1215580
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimated risk of transmission of hepatitis C virus by blood transfusion.
    Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
    Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent problems in blood transfusion (2)--transfusion of blood components (author's transl)].
    Toyama H
    Masui; 1981 May; 30(5):514-20. PubMed ID: 7277696
    [No Abstract]   [Full Text] [Related]  

  • 12. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
    Tozer RA
    P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination of blood donors--a cost-benefit analysis.
    Gesemann M; Gentner P; Scheiermann N
    Beitr Infusionsther Transfusionsmed; 1994; 32():110-2. PubMed ID: 9422105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tainted transfusion leaves Japan scrambling for safer blood tests.
    Cyranoski D
    Nat Med; 2004 Mar; 10(3):217. PubMed ID: 14991032
    [No Abstract]   [Full Text] [Related]  

  • 15. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C among blood donors in Jakarta.
    Timan IS; Latu J; Aulia D; Moeslichan S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():278-9. PubMed ID: 7886598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
    Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK
    Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HBsAg and HBsAb in haematology and blood transfusion service (author's transl)].
    Lipsic T; Geso L; Malícková D; Hrubisko M
    Cas Lek Cesk; 1980 Sep; 119(36-37):968-70. PubMed ID: 7438168
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B virus infection and transfusion medicine: science and the occult.
    Hollinger FB
    Transfusion; 2008 May; 48(5):1001-26. PubMed ID: 18454738
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.